150 related articles for article (PubMed ID: 23906889)
1. The vaccine candidate BLSOmp31 protects mice against Brucella canis infection.
Clausse M; Díaz AG; Ghersi G; Zylberman V; Cassataro J; Giambartolomei GH; Goldbaum FA; Estein SM
Vaccine; 2013 Dec; 31(51):6129-35. PubMed ID: 23906889
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.
Clausse M; Díaz AG; Ibañez AE; Cassataro J; Giambartolomei GH; Estein SM
Clin Vaccine Immunol; 2014 Dec; 21(12):1689-94. PubMed ID: 25339409
[TBL] [Abstract][Full Text] [Related]
3. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
4. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.
Estein SM; Fiorentino MA; Paolicchi FA; Clausse M; Manazza J; Cassataro J; Giambartolomei GH; Coria LM; Zylberman V; Fossati CA; Kjeken R; Goldbaum FA
Vaccine; 2009 Nov; 27(48):6704-11. PubMed ID: 19748579
[TBL] [Abstract][Full Text] [Related]
5. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Efficacy of the Brucella canis RM6/66 Δ
Stranahan LW; Chaki SP; Garcia-Gonzalez DG; Khalaf OH; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32434839
[No Abstract] [Full Text] [Related]
8. Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.
Pollak CN; Wanke MM; Estein SM; Delpino MV; Monachesi NE; Comercio EA; Fossati CA; Baldi PC
Clin Vaccine Immunol; 2015 Mar; 22(3):274-81. PubMed ID: 25540276
[TBL] [Abstract][Full Text] [Related]
9. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
10. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
11. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
12. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.
Velikovsky CA; Goldbaum FA; Cassataro J; Estein S; Bowden RA; Bruno L; Fossati CA; Giambartolomei GH
Infect Immun; 2003 Oct; 71(10):5750-5. PubMed ID: 14500496
[TBL] [Abstract][Full Text] [Related]
13. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
14. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic response of Brucella canis virB10 and virB11 mutants in a murine model.
Palomares-Resendiz E; Arellano-Reynoso B; Hernández-Castro R; Tenorio-Gutiérrez V; Salas-Téllez E; Suárez-Güemes F; Díaz-Aparicio E
Front Cell Infect Microbiol; 2012; 2():35. PubMed ID: 22919627
[TBL] [Abstract][Full Text] [Related]
17. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
18. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
[TBL] [Abstract][Full Text] [Related]
19. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.
Cassataro J; Velikovsky CA; Bruno L; Estein SM; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
Clin Vaccine Immunol; 2007 Jul; 14(7):869-74. PubMed ID: 17428946
[TBL] [Abstract][Full Text] [Related]
20. Polymeric antigen BLSOmp31 in aluminium hydroxide induces serum bactericidal and opsonic antibodies against Brucella canis in dogs.
Clausse M; Díaz AG; Pardo RP; Zylberman V; Goldbaum FA; Estein SM
Vet Immunol Immunopathol; 2017 Feb; 184():36-41. PubMed ID: 28166930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
